Background Circle Background Circle

J&J Seeks Emergency Approval of COVID Vaccine

J&J Seeks Emergency Approval of COVID Vaccine

Feb. 5, 2021 — The world’s first single-dose COVID-19 vaccine, from Johnson & Johnson, has been submitted to the U.S. Food and Drug Administration for emergency use approval.

Preliminary findings from a large international study suggest the vaccine isn’t quite as strong as the two current FDA-approved vaccines from Pfizer and Moderna, which are two-dose vaccines, the Associated Press reported.

However, the J&J vaccine is easier to use and could ease COVID-19 vaccine shortages.

An FDA advisory panel will review data on the new vaccine on Feb. 26. The FDA will then decide whether to approve it.

FDA Vaccine Chief Dr. Peter Marks has cautioned against making comparisons between vaccines before all of the evidence is collected.

“With so much need to get this pandemic under control, I think we can’t ignore any tool in the tool chest,” he told the American Medical Association last week, the AP reported. “We will have to do our best to try to make sure that we find the populations that benefit the most from each of these vaccines and deploy them in a very thoughtful manner.”

The J&J vaccine was 66% effective at preventing moderate to severe COVID-19, and 85% protective against the most serious symptoms, according to early results of the clinical trial that included 44,000 people in the United States, Latin America and South Africa, the AP reported.

And starting 28 days after receiving the vaccine, no one who got it required hospitalization or died.



WebMD News from HealthDay



Copyright © 2013-2020 HealthDay. All rights reserved.

Source link

You Might Also Like!
Risk of Death From COVID in Nursing Homes: Race Matters
Risk of Death From COVID in Nursing Homes: Race Matters

Ouslander agreed. "We all have a social responsibility," he said. "Just because you're not going into a nursing home," he ENGAGE+

When Will Kids Get COVID Vaccines?
When Will Kids Get COVID Vaccines?

MONDAY, Feb. 15, 2021 (HealthDay News) -- For parents with questions about COVID-19 vaccines and children, Johns Hopkins Medicine experts ENGAGE+

Covid in Scotland: Youngest pupils to return to classrooms
Covid in Scotland: Youngest pupils to return to classrooms

Pupils in P1 to P3 and pre-school children will go back from 22 February, it has been confirmed. Source link

COVID Death Risk Is 3.5 Times That of Influenza
COVID Death Risk Is 3.5 Times That of Influenza

MONDAY, Feb. 15, 2021 (HealthDay News) -- The risk of death from COVID-19 is more than triple that from seasonal ENGAGE+

Covid: Extra 1.7m vulnerable added to shielding list
Covid: Extra 1.7m vulnerable added to shielding list

The move brings the total to 4m in England and means vaccinations will be prioritised more quickly. Source link

Covid variants: What are they and will vaccines work?’
Covid variants: What are they and will vaccines work?’

The UK is stepping up testing to find and stop cases from spreading in the community. Source link

Covid: What are the UK's lockdown rules and when will they be reviewed?
Covid: What are the UK's lockdown rules and when will they be reviewed?

People across the country have been urged to "double down" and stick to the lockdown rules. Source link

Covid vaccine impact revealed in over-80s blood tests
Covid vaccine impact revealed in over-80s blood tests

More people in this age group in England now have detectable antibodies that can fight the virus. Source link